Prevention of Delirium in ICU Using Multimodal Interventions

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05950958
Collaborator
(none)
196
1
2
24
8.2

Study Details

Study Description

Brief Summary

This study was designed to evaluate the impact of non-pharmacological multimodal interventions including ongoing orientation, sensory correction, setting of familiar circumstance and promotion of sleep enviromnet for prevention of delirium in intensive care unit.

Condition or Disease Intervention/Treatment Phase
  • Other: Multimodal therapy for prevention of delirium
N/A

Detailed Description

Delirium significantly increases not only the length of the intensive care unit stay and overall mortality, but also the likelihood of persistant cognitive impairment after recovery. However there is no definitive treatment for delirium, thereby it is important to prevent delirium before it occur. Researches also have focused on the prevention of delirium or the reduction of duration of delirium.

Several studies evaluated the effect of non-pharmacological treatment, such as improvement of orientation, prevention of sensory deprivation, active pain control and prevention of dehydration, to reduce the occurrence of delirium and the results were inconsistent depending on the patients included. However, there have been no randomized clinical trials that have tested the effect of prevention of delirium by applying non-pharmacological multimodal approaches in the intensive care unit for Korean patients.

A randomized controlled trial was planned to evaluate the impact of on-pharmacological multimodal interventions including ongoing orientation, sensory correction, setting of familiar circumstance and promotion of sleep enviromnet for prevention of delirium in intensive care unit in Korea.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
196 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Impact of Audio and Visual Intervention in Preventing ICU Delirium in Critically Ill Patients : A Randomized Clinical Trial
Actual Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Jul 31, 2024
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Multimodal therapy group

Continuous regional cerebral oxygen saturation and processed electroencephalogram (EEG) are monitored. Multimodal therapy with conventional care are provided to prevent delirium. Ongoing orientation: 3 times per day Sensory correction: the hearing device and the glasses are supplied. Cognitive stimulation: a portable monitor is used to provide visual stimulation, and a directional speaker is used to avoid disturbing the alarm of the patient's life supportimng system. Sleep promotion: the lights are turned off from 10 pm to 7 am, and the indirect light source is used if necessary.

Other: Multimodal therapy for prevention of delirium
Multimodal therapy for prevention of delirium

No Intervention: Conventional care group

Continuous regional cerebral oxygen saturation and processed electroencephalogram (EEG) are monitored. Conventional care: If sedation is required, dexmedetomidine is considered as the first-line sedative drug. The sedation is interrupted daily and the possibility of awakening is assessed. Pain with NRS score above 3, is controlled with opioid. For patients with Richmond Agitation Sedation Scale (RASS) -4 or -5, possible items are provided.

Outcome Measures

Primary Outcome Measures

  1. Number of patients with delirium [From ICU admission up to day 28 or discharge from ICU or death]

    Delirium assessed by Confusion Assessment Method for the ICU (CAM-ICU)

Secondary Outcome Measures

  1. Delirium-free days [From ICU admission up to day 28 or discharge from ICU or death]

    Delirium assessed by Confusion Assessment Method for the ICU (CAM-ICU)

  2. Severity of delirium [From ICU admission up to day 28 or discharge from ICU or death]

    Confusion Assessment Method for the ICU-7 (CAM-ICU-7) delirium severity score

  3. Accidental extubation or disconnection of treatment devices [From ICU admission up to day 28 or discharge from ICU or death]

    Accidental extubation or disconnection of treatment devices

  4. ICU and hospital length of stay [From ICU admission up to day 28 or discharge from ICU or death]

    Duration of ICU and hospital stay

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients over 50 years who are expected to spend more than 24 hours in the intensive care unit
Exclusion Criteria:
  • Patients who developed delirium before entering the intensive care unit

  • Patients with cognitive impairment

  • Patients who have hearing or vision deficits, or have difficulty in communication

  • Patients who are expected to die within 24 hours or do not want life-sustaining treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of 03080

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Study Chair: Ho Geol Ryu, MD, PhD, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ho Geol Ryu, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05950958
Other Study ID Numbers:
  • Delirium_ICU
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ho Geol Ryu, Professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023